LSV Asset Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $162K | Hold |
7,600
| – | – | ﹤0.01% | 827 |
|
|
2026
Q1 | $133K | Hold |
7,600
| – | – | ﹤0.01% | 820 |
|
|
2025
Q4 | $149K | Hold |
7,600
| – | – | ﹤0.01% | 807 |
|
|
2025
Q3 | $209K | Buy |
+7,600
| New | +$234K | ﹤0.01% | 796 |
|
|
2022
Q4 | – | Sell |
-3,300
| Closed | -$185K | – | 888 |
|
|
2022
Q3 | $185K | Hold |
3,300
| – | – | ﹤0.01% | 796 |
|
|
2022
Q2 | $239K | Hold |
3,300
| – | – | ﹤0.01% | 800 |
|
|
2022
Q1 | $262K | Hold |
3,300
| – | – | ﹤0.01% | 804 |
|
|
2021
Q4 | $334K | Hold |
3,300
| – | – | ﹤0.01% | 798 |
|
|
2021
Q3 | $304K | Hold |
3,300
| – | – | ﹤0.01% | 809 |
|
|
2021
Q2 | $338K | Hold |
3,300
| – | – | ﹤0.01% | 816 |
|
|
2021
Q1 | $322K | Hold |
3,300
| – | – | ﹤0.01% | 835 |
|
|
2020
Q4 | $254K | Hold |
3,300
| – | – | ﹤0.01% | 856 |
|
|
2020
Q3 | $243K | Hold |
3,300
| – | – | ﹤0.01% | 857 |
|
|
2020
Q2 | $242K | Hold |
3,300
| – | – | ﹤0.01% | 881 |
|
|
2020
Q1 | $190K | Buy |
+3,300
| New | +$230K | ﹤0.01% | 862 |
|
|
2018
Q2 | – | Sell |
-21,211
| Closed | -$1.82M | – | 983 |
|
|
2018
Q1 | $1.82M | Hold |
21,211
| – | – | ﹤0.01% | 739 |
|
|
2017
Q4 | $1.57M | Hold |
21,211
| – | – | ﹤0.01% | 753 |
|
|
2017
Q3 | $1.22M | Hold |
21,211
| – | – | ﹤0.01% | 790 |
|
|
2017
Q2 | $1.36M | Hold |
21,211
| – | – | ﹤0.01% | 778 |
|
|
2017
Q1 | $1.22M | Hold |
21,211
| – | – | ﹤0.01% | 781 |
|
|
2016
Q4 | $1.3M | Sell |
21,211
-1,611
| -7% | -$105K | ﹤0.01% | 773 |
|
|
2016
Q3 | $1.58M | Hold |
22,822
| – | – | ﹤0.01% | 708 |
|
|
2016
Q2 | $1.27M | Buy |
+22,822
| New | +$1.38M | ﹤0.01% | 733 |
|
|
2015
Q3 | – | Sell |
-125,800
| Closed | -$8.6M | – | 984 |
|
|
2015
Q2 | $8.6M | Sell |
125,800
-205,000
| -62% | -$13M | 0.02% | 409 |
|
|
2015
Q1 | $18.4M | Sell |
330,800
-200
| -0.1% | -$10.3K | 0.04% | 290 |
|
|
2014
Q4 | $17M | Sell |
331,000
-317,522
| -49% | -$15.6M | 0.04% | 300 |
|
|
2014
Q3 | $23.9M | Sell |
648,522
-38,200
| -6% | -$1.38M | 0.05% | 242 |
|
|
2014
Q2 | $26.8M | Buy |
686,722
+2,034
| +0.3% | +$75.5K | 0.06% | 228 |
|
|
2014
Q1 | $25.8M | Buy |
684,688
+5,566
| +0.8% | +$194K | 0.06% | 221 |
|
|
2013
Q4 | $25.7M | Sell |
679,122
-121,678
| -15% | -$4.66M | 0.06% | 228 |
|
|
2013
Q3 | $34.8M | Sell |
800,800
-552,548
| -41% | -$22.2M | 0.09% | 193 |
|
|
2013
Q2 | $49M | Buy |
+1,353,348
| New | +$41.1M | 0.13% | 153 |
|
Other funds holding USNA
SO
UA
LSV Asset Management's USNA Position: Q2 2026 in Review
LSV Asset Management held its Usana Health Sciences (USNA) position steady in Q2 2026 at 7,600 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #827.
LSV Asset Management first reported a position in USNA in Q2 2013 and has held it in 32 quarters since. The position peaked at $49M in Q2 2013. 50 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- LSV Asset Management held 7,600 shares of Usana Health Sciences worth $162K as of Q2 2026.
- LSV Asset Management left its Usana Health Sciences share count unchanged in Q2 2026.
- Usana Health Sciences made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #827 holding.
- LSV Asset Management first reported a position in Usana Health Sciences in Q2 2013 and has held it in 32 quarters since.
- LSV Asset Management's Usana Health Sciences position peaked at $49M in Q2 2013.
- 50 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.